David is a 30-year veteran of the biopharmaceutical industry and has expertise in early-stage company building and operating large multinational biotech companies. He is Chairman & CEO of ElevateBio and AlloVir, an ElevateBio portfolio company. 

Previously, David spent more than a decade at Alexion Pharmaceuticals as CEO, Chief Operating Officer, and Chief Commercial Officer and brought the company from the pre-commercial stage to greater than $3 billion in annual revenues. Before joining Alexion, he held commercial leadership positions at Amgen, Biogen, and Eyetech Pharmaceuticals and expanded the adoption of first-in-class products in hematology, oncology, nephrology, immunology and ophthalmology.

David is currently Chairman of the Board at both iTelos Therapeutics, an MPM Capital portfolio company, and Scholar Rock, and serves on the board at Seer. He received his BA in psychology from the University of New Hampshire.